Effects of n-3 PUFA on insulin resistance after an oral fat load

European Journal of Lipid Science and Technology

Volumn 113, Issue 8, 2011, Pages 950-960

  Derosa, Giuseppe ^b   Cicero, Arrigo F G ^a   Fogari, Elena ^a   D'Angelo, Angela ^a   Bonaventura, Aldo ^a   Maffioli, Pamela ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Adiponectin; Insulin resistance; n 3 PUFA; Oral fat load; Resistin

Indexed keywords

EID: 80051703255     PISSN: 14387697     EISSN: 14389312     Source Type: Journal    
DOI: 10.1002/ejlt.201000504     Document Type: Article

References (51)

1. McGandy, R. B., Hegsted, D. N. I., Stare, F. J., Dietary fats, carbohydrates and atherosclerotic vascular disease. New Engl. J. Med. 1967, 277, 245-247.
2. Keys, A., Current status of research on the epidemiology of coronary heart disease. Jpn. Circ. J. 1968, 32, 1669.
3. Keys, A., The diet and the problem of coronary heart disease. Minerva Med. 1970, 61, 173.
4. Simopoulos, A. P., Importance of the ratio of omega-6/omega-3 essential fatty acids: Evolutionary aspects. World Rev. Nutr. Diet. 2003, 92, 1-22.
5. DeFilippis, A. P., Sperling, L. S., Understanding omega-3's. Am. Heart J. 2006, 151, 564-570.
6. Dyerberg, J., Bang, H. O., Hjorne, N., Fatty acid composition of the plasma lipids in Greenland Eskimos. Am. J. Clin. Nutr. 1975, 28, 958-966.
7. GISSI-Prevenzione Investigators (Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico), Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: Results of the GISSI-Prevenzione trial. Lancet 1999, 354, 447-455.
8. Marchioli, R., On behalf of GISSI-prevenzione investigators, treatment with polyunsaturated fatty acids after myocardial infarction: Results of GISSI-Prevenzione trial. Eur. Heart J. 2001, 3, D85-96.
9. Macchia, A., Levantesi, G., Franzosi, M. G., Geraci, E., et al., For GISSI-prevenzione investigators, left ventricular systolic dysfunction, total mortality, and sudden death in patients with myocardial infarction treated with n-3 polyunsaturated fatty acids. Eur. J. Heart Fail. 2005, 7, 904-909.
10. Marchioli, R., Levantesi, G., Macchia, A., Maggioni, A. P., et al., For GISSI-prevenzione investigators, antiarrhythmic mechanisms of n-3 PUFA and the results of the GISSI-Prevenzione trial. J. Membr. Biol. 2005, 206, 117-128.
11. Wang, C., Harris, W. S., Chung, M., Lichtenstein, A. H., et al., n-3 Fatty acids from fish or fish-oil supplements, but not alpha-linoleic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: A systematic review. Am. J. Clinic. Nutr. 2006, 84, 5-17.
12. Derosa, G., Maffioli, P., D'Angelo, A., Salvadeo, S. A., et al., Effects of long chain omega-3 fatty acids on metalloproteinases and their inhibitors in combined dyslipidemia patients. Expert Opin. Pharmacother. 2009, 10, 1239-1247.
13. Cicero, A. F., Derosa, G., Di Gregori, V., Bove, M., et al., Omega 3 polyunsaturated fatty acids supplementation and blood pressure levels in hypertriglyceridemic patients with untreated normal-high blood pressure and with or without metabolic syndrome: A retrospective study. Clin. Exp. Hypertens. 2010, 32, 137-144.
14. Nordestgaard, B. G., Benn, M., Schnohr, P., Tybjaerg-Hansen, A., Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA 2007, 298, 299-308.
15. Karpe, F., Steiner, G., Uffelman, K., Olivecrona, T., Hamsten, A., Postprandial lipoproteins and progression of coronary atherosclerosis. Atherosclerosis 1994, 106, 83-97.
16. Parks, E. J., Recent findings in the study of postprandial lipemia. Curr. Atheroscler. Rep. 2001, 3, 462-470.
17. Halkes, C. J., van Dijk, H., de Jaegere, P. P., Plokker, H. W., et al., Postprandial increase of complement component 3 in normolipidemic patients with coronary artery disease: Effects of expanded-dose simvastatin. Arterioscler. Thromb. Vasc. Biol. 2010, 21, 1526-1530.
18. Alipour, A., Elte, J. W., van Zaanen, H. C., Rietveld, A. P., Cabezas, M. C., Postprandial inflammation and endothelial dysfuction. Biochem. Soc. Trans. 2007, 35, 466-469.
19. Norata, G. D., Grigore, L., Raselli, S., Redaelli, L., et al., Post-prandial endothelial dysfunction in hypertriglyceridemic subjects: Molecular mechanisms and gene expression studies. Atherosclerosis 2007, 193, 321-327.
20. Tsai, W. C., Li, Y. H., Lin, C. C., Chao, T. H., Chen, J. H., Effects of oxidative stress on endothelial function after a high-fat meal. Clin. Sci. 2004, 106, 315-319.
21. Jastrzebska, M., Przybycień, K., Chelstowski, K., Torbus-Lisiecka, B., et al., Postprandial lipoproteins and progression of coronary atherosclerosis. Atherosclerosis 1994, 106, 83-97.
22. Silveira, A., Karpe, F., Blombäck, M., Steiner, G., et al., Activation of coagulation factor VII during alimentary lipemia. Arterioscler. Thromb. 1994, 14, 60-69.
23. Gotto, A. M. Jr., Amarenco, P., Assman, G., et al. The ILIB Lipid Handbook for Clinical Practice: Dyslipidemia and Coronary Heart Disease, 3rd Edition, International Lipid Information Bureau, New York 2003, pp. 1-242.
24. Lichtenstein, A. H., Appel, L. J., Brands, M., Carnethon, M., et al., Summary of American Heart Association diet and lifestyle recommendations revision. Arterioscler. Thromb. Vasc. Biol. 2006, 26, 2186-2191.
25. Derosa, G., Maffioli, P., Salvadeo, S. A., Ferrari, I., et al., Differential effects of candesartan and olmesartan on adipose tissue activity biomarkers in type II diabetic hypertensive patients. Hypertens. Res. 2010, 33, 790-795.
26. Derosa, G., Maffioli, P., Salvadeo, S. A., Ferrari, I., et al., Effects of combination of sibutramine and l-carnitine compared with sibutramine monotherapy on inflammatory parameters in diabetic patients. Metabolism 2011, 60, 421-429.
27. Winer, B. J., Statistical Principles in Experimental Design, 2nd Edn., McGraw-Hill, New York 1971.
28. Kinsella, J. E., Effects of polyunsaturated fatty acids on factors related to cardiovascular disease. Am. J. Cardiol. 1987, 60, 23G-32G.
29. Ebrahimi, M., Ghayour-Mobarhan, M., Rezaiean, S., Hoseini, M., et al., Omega-3 fatty acid supplements improve the cardiovascular risk profile of subjects with metabolic syndrome, including markers of inflammation and auto-immunity. Acta Cardiol. 2009, 64, 321-327.
30. Simão, A. N., Godeny, P., Lozovoy, M. A., Dichi, J. B., Dichi, I., Effect of n-3 fatty acids in glycemic and lipid profiles, oxidative stress and total antioxidant capacity in patients with the metabolic syndrome. Arq. Bras. Endocrinol. Metabol. 2010, 54, 463-469.
31. Steppan, C. M., Bailey, S. T., Bhat, S., Brown, E. J., et al., The hormone resistin links obesity to diabetes. Nature (London) 2001, 409, 307-312.
32. Satoh, H., Nguyen, M. T., Miles, P. D., Imamura, T., et al., Adenovirus-mediated chronic 'hyper-resistinemia' leads to in vivo insulin resistance in normal rats. J. Clin. Invest. 2004, 114, 224-231.
33. Rangwala, S. M., Rich, A. S., Rhoades, B., Abnormal glucose homeostasis due to chronic hyperresistinemia. Diabetes 2004, 53, 1937-1941.
34. Reilly, M. P., Lehrke, M., Wolfe, M., Rohatgi, A., et al., Resistin is an inflammatory marker of atherosclerosis in humans. Circulation 2005, 111, 932-939.
35. Cho, Y. M., Youn, B. S., Lee, H., Lee, N., et al., Plasma retinol-binding protein-4 concentrations are elevated in human subjects with impaired glucose tolerance and type 2 diabetes. Diabetes Care 2006, 29, 2457-2461.
36. Jackson, M. B., Ahima, R. S., Neuroendocrine and metabolic effects of adipocyte-derived hormones. Clin. Sci. 2006, 110, 143-152.
37. Berg, A. H., Combs, T. P., Scherer, P. E., ACRP30/adiponectin: An adipokine regulating glucose and lipid metabolism. Trends Endocrinol. Metab. 2002, 13, 84-89.
38. Bouskila, M., Pajvani, U. B., Scherer, P. E., Adiponectin: A relevant player in PPARγ-agonist mediated improvements in hepatic insulin sensitivity? Int. J. Obes. Relat. Metab. Disord. 2005, 29, S17- S23.
39. Maeda, N., Shimomura, I., Kishida, K., Nishizawa, H., et al., Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat. Med. 2002, 8, 731-737.
40. Berg, A. H., Combs, T. P., Du, X., Brownlee, M., Scherer, P. E., The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat. Med. 2001, 7, 947-953.
41. Fukuhara, A., Matsuda, M., Nishizawa, M., Segawa, K., et al., Visfatin: A protein secreted by visceral fat that mimics the effects of insulin. Science 2005, 307, 426-430.
42. Hug, C., Lodish, H. F., Visfatin: A new adipokine. Science 2005, 307, 366-367.
43. Hida, K., Wada, J., Eguchi, J., Zhang, H., et al., Visceral adipose tissue-derived serine protease inhibitor: A unique insulinsensitizing adipocytokine in obesity. Proc. Natl. Acad. Sci. 2005, 102, 10610-10615.
44. Thorseng, T., Witte, D. R., Vistisen, D., Borch-Johnsen, K., et al., The association between n-3 fatty acids in erythrocyte membranes and insulin resistance: The inuit health in transition study. Int. J. Circumpolar. Health 2009, 68, 327-336.
45. Huang, T., Wahlqvist, M. L., Xu, T., Xu, A., et al., Increased plasma n-3 polyunsaturated fatty acid is associated with improved insulin sensitivity in type 2 diabetes in China. Mol. Nutr. Food Res. 2010, 54, 112-119.
46. Moreno-Aliaga, M. J., Lorente-Cebrián, S., Martínez, J. A., Regulation of adipokine secretion by n-3 fatty acids. Proc. Nutr. Soc. 2010, 69, 324-332.
47. Hassanali, Z., Ametaj, B. N., Field, C. J., Proctor, S. D., Vine, D. F., Dietary supplementation of n-3 PUFA reduces weight gain and improves postprandial lipaemia and the associated inflammatory response in the obese JCR:LA-cp rat. Diabetes Obes. Metab. 2010, 12, 139-147.
48. Montegaard, C., Tulk, H. M. F., Lauritzen, L., Tholstrup, T., Robinson, L. E., Acute ingestion of long-chain (n-3) polyunsaturated fatty acids decreases fibrinolysis in men with metabolic syndrome. J. Nutr. 2010, 140, 38-43.
49. Whelton, S. P., He, J., Whelton, P. K., Muntner, P., Meta-analysis of observational studies on fish intake and coronary heart disease. Am. J. Cardiol. 2004, 93, 1119-1123.
50. Bucher, H. C., Hengstler, P., Schindler, C., Meier, G., n-3 Polyunsaturated fatty acids in coronary heart disease: A meta-analysis of randomised controlled trials. Am. J. Med. 2002, 112, 298-304.
51. Ghafoorunissa, A. I., Rajkumar, L., Acharya, V., Dietary (n-3) long chain polyunsaturated fatty acids prevent sucrose-induced insulin resistance in rats. J. Nutr. 2005, 135, 2634-2638.